socalTECH

MAY 30, 2017

San Diego-based Arcturus Therapeutics , a developer of mRNA-based treatments for disease, has signed a deal to receive up to $3M in funding from the Cystic Fibrosis Foundation Therapeutics, a nonprofit which supports drug discovery and development. READ MORE>>.

Arcturus 167

Arcturus San Diego Develop Development 167

socalTECH

JUNE 15, 2010

Monrovia, California-based Prolacta Bioscience , the venture backed firm developing human milk fortifiers for premature infants, announced this morning that it will be donating funds to the Susan G. The firm said it will commit a minimum amount of $25,000 annually to fund programs at Komen.

Arcturus 221

Arcturus Draper Monrovia Funding 221

socalTECH

NOVEMBER 9, 2020

San Diego-based Arcturus Therapeutics has received up to $220M in additional financial commitments from the country of Singapore, after receiving positive Phase 1/2 study results on one of its compounds. READ MORE>>.

Arcturus 113

Arcturus Study San Diego Funding 113

socalTECH

NOVEMBER 17, 2022

Los Angeles-based Arcturus, a developer of 3D video editing tools, said Wednesday afternoon that it has raised $11M in a Series A funding round. The funding was led by Cloudtree Ventures, and also included Autodesk and Epic Games. The startup is led by CEO Kamal Mistry.

Arcturus 100

Arcturus Tool Los Angeles Content 100

socalTECH

JANUARY 22, 2009

Santa Monica-based Zag , which has developed an automobile configuration and buying service for affinity organizations like credit unions and automobile organizations, has a funding round of undisclosed size. Tags: automobile venture auto capital funding. READ MORE>>.

Zag 100

Zag Funding Tech Coast Angels Arcturus 100

socalTECH

SEPTEMBER 23, 2011

Prolacta has been developing processes which process human milk, and convert that into human milk fortifier which helps prevent medical issues often encountered by feeding premature babies with cow-based fortifiers. According to Prolacta, the National Milk Bank will recruit potential breast milk donors for Prolacta. READ MORE>>.

Arcturus 166

Arcturus Draper Monrovia Capital 166

Xconomy

MAY 30, 2017

San Diego-based Arcturus Therapeutics said today Cystic Fibrosis Foundation Therapeutics has agreed to provide $3 million to fund research and development of a new messenger RNA drug that could be broadly used to treat cystic fibrosis patients. Arcturus says its technology can be used to make.

Arcturus 65

Arcturus San Diego Research Funding 65